Rights Issue

June 26, 2026 BSE Limited National Stock Exchange of India Ltd. Corporate Relationship Department Exchange Plaza, P.J. Towers, Bandra-Kurla Complex, Dalal Street, Fort, Bandra (East) Mumbai - 400 001 Mumbai - 400 051 Scrip Code : 506109 Symbol : GENESYS Sub: Outcome of Board Meeting held on June 26, 2026 under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, In furtherance to our prior intimation dated June 23, 2026 and pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), the Board of Directors of Genesys International Corporation Limited (“the Company”) at their meeting held today i.e. Friday, June 26, 2026 has considered and, inter alia, approved the issue of Equity Shares of the Company of face value of Rs. 5/- each (the “Equity Shares”) for an amount up to and not exceeding Rs. 13,930 Lakhs by way of Rights Issue to the eligible Shareholders of the Company as on the record date (to be determined and notified subsequently, and such issue, the “Rights Issue”), in accordance with applicable laws, including the Companies Act, 2013, as amended, the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 (the “SEBI ICDR Regulations”), as amended, subject to such regulatory and statutory approvals, as may be relevant under the applicable laws. The Board also approved the constitution of the Rights Issue Committee, for the purposes of issue, offer and allotment of Equity Shares, and other matters in connection with or incidental to the Rights Issue. For the purposes of giving effect to the Rights Issue, the specific and detailed terms in relation to the Rights Issue, including but not limited to, the determination of the issue price, rights entitlement ratio, record date, timing of the rights issue and terms of payment will be determined by the Board and / or a duly constituted Committee of the Board of Directors authorized in this regard. The meeting of the Board of Directors commenced at 11.35 a.m. and concluded at 11.56 a.m. This disclosure is made in terms of Regulation 30 read with Schedule III and other applicable provisions of the Listing Regulations, read with SEBI Master Circular No. Regd. Office: 73-A, SDF-III, SEEPZ, Andheri (E), Mumbai-400 096, India Tel.: +91-22-2829 0303; +91-22-4488 4488; Fax: +91-22-2829 0603 Website: www.igenesys.com; E-mail:investors@igenesys.com CIN: L65990MH1983PLC029197 HO/49/14/14(2)2026-CFD-POD2/II/4518/2026 dated June 21, 2023, last updated on February 09, 2026, as amended/updated from time to time and enclosed as Annexure-A. We request you to please take the above information on your records. The copy of the same is also being made available on the website of the Company at www.igenesys.com. Thanking You, Yours Faithfully, for Genesys International Corporation Limited Kushal Jain Company Secretary & Compliance Officer Regd. Office: 73-A, SDF-III, SEEPZ, Andheri (E), Mumbai-400 096, India Tel.: +91-22-2829 0303; +91-22-4488 4488; Fax: +91-22-2829 0603 Website: www.igenesys.com; E-mail:investors@igenesys.com CIN: L65990MH1983PLC029197 ANNEXURE A Disclosures as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 S. No. Particulars Details 1. type of securities proposed to be issued Equity Shares (viz. equity shares, convertibles etc.) 2. type of issuance (further public offering, Rights Issue rights issue, depository receipts (ADR/GDR), qualified institutions placement, preferential allotment etc.) 3. total number of securities proposed to be For an amount upto and issued or the total amount for which the not exceeding Rs. 13,930 securities will be issued (approximately) Lakhs Regd. Office: 73-A, SDF-III, SEEPZ, Andheri (E), Mumbai-400 096, India Tel.: +91-22-2829 0303; +91-22-4488 4488; Fax: +91-22-2829 0603 Website: www.igenesys.com; E-mail:investors@igenesys.com CIN: L65990MH1983PLC029197